Diagnosis: |
From symptoms to underlying diagnosis with the support of imaging |
Diagnostic procedure: |
Imaging procedures tailored to the clinical problem and patient characteristics |
Prevention/screening: |
Imaging to improve risk stratification or to detect preclinical disease |
Selection of the right treatment with imaging information |
Imaging to assess the localisation and extent disease |
Imaging for functional and biological characterisation of lesions |
Image-guided biopsy to get specimens for genetic/molecular characterisation |
Imaging biomarkers to predict response to treatment, recurrence and survival |
Agents that can be used for imaging diagnostics and therapeutic purposes (theranostics) |
Imaging biomarkers associated with genetic/molecular features (radiogenomics) |
Evaluation of treatment response: |
Imaging to assess early the effects of treatment in order to adapt treatment |
Imaging in drug discovery and drug trials: |
Surrogate imaging biomarkers to evaluate the effect of new personalised treatment |
Personalised treatment: |
Image-guided treatment with surgical, radiotherapeutical, minimally or non-invasive interventional procedures |